United States · FDA National Drug Code directory
Oxymorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0283_74519e3e-078f-42ea-882e-1df0eb0eaaee
- Product NDC
- 0054-0283
- Form
- TABLET
- Composition / generic term
- oxymorphone hydrochloride
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100927
- Source listing expiry
- 20261231
Source-listed ingredients
- OXYMORPHONE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (0054-0283-25) · 0054-0283-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →